Fourth Quarter 2011 incl. Süd-Chemie* |  | Full Year 2011 incl. Süd-Chemie* |
 |
| Consensus | Median |
| Sales | 1854 | 1857 |
| EBITDA before exceptionals | 199 | 203 |
| Margin % | 10.7 % | 10.9 % |
Operating Income before
exceptionals | 131 | 131 |
| Margin % | 7.1 % | 7.1 % |
| Operating Income | 75 | 79 |
Net income from continuing
operations | 32 | 31 |
| Net result | 26 | 27 |
| |
| Consensus | Median |
| Sales | 7305 | 7309 |
| EBITDA before exceptionals | 933 | 937 |
| Margin % | 12.8 % | 12.8 % |
Operating Income before
exceptionals | 683 | 683 |
| Margin % | 9.3 % | 9.3 % |
| Operating Income | 549 | 553 |
Net income from continuing
operations | 273 | 272 |
| Net result | 247 | 249 |
|
Full Year 2012 incl. Süd-Chemie* | | |
|
| Consensus | Median |
| Sales | 7429 | 7485 |
| EBITDA before exceptionals | 870 | 860 |
| Margin % | 11.7 % | 11.5 % |
Operating Income before
exceptionals | 581 | 555 |
| Margin % | 7.8 % | 7.4 % |
| Operating Income | 460 | 460 |
Net income from continuing
operations | 224 | 212 |
| Net result | 206 | 189 |
| | |
Disclaimer: Consensus earnings estimates are based on earnings projections made by equity analysts who cover Clariant. Any opinions, forecasts, estimates, projections or predictions regarding Clariant’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of Clariant or its management. Clariant does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. Clariant assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.
|
